The FDA’s Center for Biologics Evaluation and Research (CBER) is launching a pilot program for sponsors of medical devices regulated by the center that wish to use the voluntary Electronic Submission Template and Resource (eSTAR) to provide premarket notification (510(k)) submissions to the agency electronically. The program is intended to improve consistency and efficiency i... Read More